September 15, 2022
Vicore provides an update on the ATTRACT-3 COVID-19 trial
Media
September 12, 2022
Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies
September 12, 2022
Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds
September 07, 2022
Oncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myeloma
September 04, 2022
CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
September 02, 2022
Vicore update on the AIR phase 2 trial in idiopathic pulmonary fibrosis
August 31, 2022
Emactuzumab designated as an Orphan Medicinal Product in Europe
August 29, 2022
Fusion Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Study Of FPI-1966 In Patients With Advanced Solid Tumors Expressing FGFR3
August 25, 2022
Interim report April – June 2022
August 19, 2022
Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn